Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Nevin DİNÇÇAĞ
Use of Biphasic Insulin Aspart 30 in Type 2 Diabetes Treatment: Expert Panel Recommendations
Turkish Journal of Endocrinology and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
Related publications
15 Years of Experience With Biphasic Insulin Aspart 30 in Type 2 Diabetes
Drugs in R and D
Pharmacology
Comparison of a Soluble Co-Formulation of Insulin Degludec/Insulin Aspart vs Biphasic Insulin Aspart 30 in Type 2 Diabetes: A Randomised Trial
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Budget Impact Analysis of Biphasic Insulin Aspart in the Treatment of Type 2 Diabetes Mellitus in Malaysia: A Public Payer Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Initiation of Biphasic Insulin Aspart in a Patient Failing Basal Insulin Treatment
European Endocrinology
Endocrine
Endocrinology
Metabolism
Autonomic Systems
Diabetes
Safety and Effectiveness of Biphasic Insulin Aspart 30/70 (NovoMix®30) When Switching From Human Premix Insulin in Patients With Type 2 Diabetes: Subgroup Analysis From the 6-Month IMPROVE™ Observational Study
International Journal of Clinical Practice
Medicine
Safety and Effectiveness of Biphasic Insulin Aspart 30 in Different Age-Groups: A1chieve Sub-Analysis
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Efficacy and Safety of Three-Times-Daily Versus Twice-Daily Biphasic Insulin Aspart 30 in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Combined With Oral Antidiabetic Drugs
Diabetes Research and Clinical Practice
Internal Medicine
Endocrinology
Metabolism
Medicine
Diabetes
Biphasic Insulin Aspart 30 Therapy in Insulin-Naïve and Insulin-Experienced Patients With Type 2 Diabetes: Results From the Jordanian Subgroup of the A<sub>1</Sub>chieve Study
Journal of Diabetes Mellitus
A Survey of Physician Experience and Treatment Satisfaction Using Fast-Acting Insulin Aspart in People With Type 1 or Type 2 Diabetes
Postgraduate Medicine
Medicine
